Authors: Bleumink, GS ter Borg, EJ Ramselaar, CG Stricker, BHC

Citation: Gs. Bleumink et al., Etanercept-induced subacute cutaneous lupus erythematosus, RHEUMATOLOG, 40(11), 2001, pp. 1317-1319

Authors: van Jaarsveld, CHM Jahangier, ZN Jacobs, JWG Blaauw, AAM van Albada-Kuipers, GA ter Borg, EJ Brus, HLM Schenk, Y van der Veen, MJ Bijlsma, JWJ

Citation: Chm. Van Jaarsveld et al., Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis, RHEUMATOLOG, 39(12), 2000, pp. 1374-1382

Authors: van Jaarsveld, CHM Jacobs, JWG van der Veen, MJ Blaauw, AAM Kruize, AA Hofman, DM Brus, HLM van Albada-Kuipers, GA Heurkens, AHM ter Borg, EJ Haanen, HCM van Booma-Frankfort, C Schenk, Y Bijlsma, JWJ

Citation: Chm. Van Jaarsveld et al., Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial, ANN RHEUM D, 59(6), 2000, pp. 468-477

Authors: ter Borg, EJ Gerards-Rociu, E Haanen, HCM Westers, P

Citation: Ej. Ter Borg et al., High frequency of hysterectomies and appendectomies in fibromyalgia compared with rheumatoid arthritis: A pilot study, CLIN RHEUMA, 18(1), 1999, pp. 1-3

Authors: van Jaarsveld, CHM ter Borg, EJ Jacobs, JWG Schellekens, GA Gmelig-Meyling, FHJ van Booma-Frankfort, C de Jong, BAW van Venrooij, WJ Bijlsma, JWJ

Citation: Chm. Van Jaarsveld et al., The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis, CLIN EXP RH, 17(6), 1999, pp. 689-697